Michael A. Becker - Concepedia

Author

Michael A. Becker

Also Known As

, Becker, Michael, Becker, Michael A, Becker, Michael A., M A Becker, M BECKER, M Becker, M. A. Becker, M. Becker, M.A. Becker

Publications

14.8K

Citations

H-Index

248

Concepts

All Affiliations

University of Chicago University of California San Diego United States Department of Veterans Affairs University of Michigan University of Pennsylvania

About

Michael A. Becker is an author at University of Chicago specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	807
2	Law	3	3	112
3	Arts	2	2	145
4	Education	1	1	20
5	Health Sciences	1	1	35

Michael A. Becker

130

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann, New England Journal of Medicine	2005	1.3K
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout William B. White, Kenneth G. Saag, Michael A. Becker, New England Journal of Medicine	2018	860
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial H. Ralph Schumacher, Michael A. Becker, Robert L. Wortmann, Arthritis Care & Research Renal InflammationPharmacotherapyGout FlaresRenal FunctionFebuxostat Versus Allopurinol	2008	623
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial Michael A. Becker, H. Ralph Schumacher, Luis R. Espinoza, Arthritis Research & Therapy	2010	519
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment John S. Sundy, Herbert S. B. Baraf, Robert A. Yood, JAMA	2011	508
Generation and analysis of 280,000 human expressed sequence tags. L. Hillier, Gregory G. Lennon, Michael A. Becker, Genome Research Gene FamiliesEngineeringTaggingGeneticsMolecular Biology	1996	467
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase Yasuhiro Takano, Kumiko Hase-Aoki, Hideki Horiuchi, Life Sciences Novel Non-purine InhibitorXanthine Oxidase/xanthine DehydrogenaseOxysterolBiochemistryMedicine	2005	325
Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout Michael A. Becker, H. Ralph Schumacher, Patricia MacDonald, The Journal of Rheumatology	2009	271
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann, Arthritis & Rheumatism	2005	267
Pairwise multiple comparison procedures: A review. James Jaccard, Michael A. Becker, Gregory Wood Psychological Bulletin Methodology ComparisonComparative TestStatisticsEvaluation	1984	260

Page 1